Traws Pharma, Inc. Deferred Revenue (Non-Current)
Traws Pharma, Inc. (TRAW) had Deferred Revenue (Non-Current) of $4.09 million as of 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2018-03-16
- 2017-12-31: Deferred Revenue, Noncurrent $4.09M.
- 2017-09-30: Deferred Revenue, Noncurrent $4.21M.
- 2017-06-30: Deferred Revenue, Noncurrent $4.32M.
- 2017-03-31: Deferred Revenue, Noncurrent $4.43M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2017-12-31 | $4.09M 10-K · filed 2018-03-16 |
| 2017-09-30 | $4.21M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $4.32M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $4.43M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $4.54M 10-K · filed 2018-03-16 |
| 2016-09-30 | $4.66M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $4.77M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $4.89M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $5.00M 10-K · filed 2017-03-29 |
| 2015-09-30 | $13.11M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $13.23M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $13.34M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $13.46M 10-K · filed 2016-03-28 |
| 2014-09-30 | $13.57M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $13.68M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $13.79M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $13.91M 10-K · filed 2015-03-30 |
| 2013-09-30 | $14.02M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $14.14M 10-Q · filed 2013-09-06 |
| 2012-12-31 | $15.42M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |